- Assistant Professor, CWRU School of Medicine
- Amyotrophic Lateral Sclerosis (ALS)
- Carpal Tunnel Syndrome
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Electromyography (EMG)
- Entrapment Neuropathies
- Myasthenia Gravis (MG)
- Nerve Conduction Studies (NCS)
- Peripheral Neuropathies
- Ulnar Neuropathies
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Beachwood OH, 44122
Patient Experience Reviews
4.5 out of 5
Patient Comments (6)
Reviewed On 6/1/2022
I had a very good visit with Dr Sawlani. She was most thorough and answered all my questions completely.
Reviewed On 6/1/2022
Excellent visit(s) - very good communication from doctors and staff. I definitely feel that I was paid attention to, that my needs were considered important, and that the team had interest in moving towards a desired outcome.
Reviewed On 5/1/2022
I must say my experience with Dr Sawlani has always been good.
Reviewed On 3/1/2022
Dr Sawlani answered all my questions and concerns as well as those of my family that were present at the zoom session
Reviewed On 2/1/2022
The care from the Dr. Is great. I have multiple health issues and her plan of treatment involves the recommendations of my whole medical team at UH. ***
Reviewed On 8/1/2021
I love Dr Sawlani she's one of the best Drs I have seen in my life.
- Neuromuscular Medicine - American Board of Psychiatry and Neurology
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Neuromuscular Disease
Neuromuscular Disease - Brigham And Women's Hospital (2015 - 2016)
Residency | Neurology
Neurology - Uh Case Medical Center (2011 - 2015)
Indiana University School Of Medicine (2011)
Northwestern University (2007)
Neuromuscular Disorders, Amyotrophic Lateral Sclerosis, EMG and Nerve conduction studies, Spinal muscular atrophy, Myasthenia Gravis
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Komal Sawlani did not disclose any Outside Relationships with Industry.